LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

AngioDynamics, Inc. ANGO recently announced the completion of the sale of its PICC and Midline product portfolios to Spectrum Vascular for $45 million in cash. AngioDynamics' PICC, Midline, and tip ...

The incidence of catheter-related bloodstream infections was low in patients with midline vs peripherally inserted central catheters, but the use of midline catheters was associated with increased ...

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today announced findings ...

Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device.

BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...

Midline catheters and vascular access devices (VADs) play a pivotal role in modern clinical practice by offering less invasive alternatives to central venous access. Midline catheters, which are ...

LATHAM, N.Y. - Medical technology firm AngioDynamics , Inc. (NASDAQ: NASDAQ: ANGO) has divested its peripherally inserted central catheter (PICC) and Midline product lines to Spectrum Vascular for a ...